Therapeutic options for preservation of residual renal function in patients on peritoneal dialysis

Peritoneal Dialysis International

Volumn 27, Issue SUPPL. 2, 2007, Pages

  Li, Philip Kam Tao ^a   Cheng, Yuk Lun ^b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b ALICE HO MIU LING NETHERSOLE HOSPITAL   (Hong Kong)

Author keywords

Renoprotective strategy; Residual renat function

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CALCIUM CHANNEL BLOCKING AGENT; CONTRAST MEDIUM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ERYTHROPOIETIN; FUROSEMIDE; LOOP DIURETIC AGENT; NETILMICIN; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHATE BINDING AGENT; RAMIPRIL; VALSARTAN;

BLOOD PRESSURE REGULATION; CLINICAL TRIAL; CONFERENCE PAPER; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; COST CONTROL; DRUG MEGADOSE; EVIDENCE BASED MEDICINE; HUMAN; INFLAMMATION; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; KIDNEY PRESERVATION; MORBIDITY; NEPHROTOXICITY; NUTRITIONAL HEALTH; OTOTOXICITY; OUTCOMES RESEARCH; PERITONEAL DIALYSIS; PERITONITIS; PRIORITY JOURNAL; PROTEINURIA; QUALITY OF LIFE; RENAL PROTECTION; RENAL REPLACEMENT THERAPY; SURVIVAL RATE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CLINICAL TRIALS AS TOPIC; CONTRAST MEDIA; DIALYSIS SOLUTIONS; HUMANS; HYPOTENSION; KIDNEY; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; PERITONEAL DIALYSIS; PERITONITIS; PROGNOSIS;

EID: 35748954657     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (33)

1. Szeto CC, Wong TYH, Leung CB, Wang AYM, Law MC, Lui SF, et al. Importance of dialysis adequacy in mortality and morbidity of Chinese CAPD patients. Kidney Int 2000; 58: 400-7.
2. Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 2001; 12:2158-62.
3. Li PK, Chow KM. The clinical and epidemiological aspects of vascular mortality in chronic peritoneal dialysis patients. Perit Dial Int 2005; 25(Suppl 3):S80-3.
4. Szeto CC, Wong TYH, Chow KM, Leung CB, Li PK. Are peritoneal dialysis patients with and without residual renal function equivalent for survivalstudy? Insight from a retrospective review of the cause of death. Nephrol Dial Transplant 2003; 18:977-82.
5. Wang AY, Woo J, Wang M, Sea MM, Sanderson JE, Lui SF, et al. Important differentiation of factors that predict outcome in peritoneal dialysis patients with different degrees of residual renal function. Nephrol Dial Transplant 2005; 20:396-403.
6. Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, et al. Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 2000; 11: 556-64.
7. Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 2002; 62:1046-53.
8. Korevaar JC, Feith GW, Dekker FW, van Manen JG, Boeschoten EW, Bossuyt PM, et al. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int 2003; 64:2222-8.
9. Li PK, Chow KM. The cost barrier to peritoneal dialysis in the developing world - an Asian perspective. Perit Dial Int 2001; 21(Suppl 3):SJ07-13.
10. Li PK, Szeto CC. Adequacy targets of peritoneal dialysis in the Asian population. Perit Dial Int 2001; 21(Suppl 3): SJ78-83.
11. Lo WK, Bargman JM, Burkart J, Krediet RT, Pollock C, Kawanishi H, et al. Guideline on targets for solute and fluid removal in adult patients on chronic peritoneal dialysis, Perit Dial Int 2006; 26:520-2.
12. Bammens B, Evenepoel P, Verbeke K, Vanrenterghem Y. Time profiles of peritoneal and renal clearances of different uremic solutes in incident peritoneal dialysis patients. Am J Kidney Dis 2005; 46:512-19.
13. Wang AY, Wang M, Woo J, Law MC, Chow KM, Li PK, et al. A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int 2002; 62:639-47.
14. Churchill DN, Taylor DW, Keshaviah PR, and the CANUSA Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes, J Am Soc Nephrol 1996; 7:198-207.
15. Young GA, Kopple JD, Lindholm B, Vonesh EF, De Vecchi A, Scabamogna A, et al. Nutritional assessment of continuous ambulatory peritoneal dialysis patients: an international study. Am J Kidney Dis 1991; 17:462-71.
16. Wang AY, Sea MM, Ip R, Law MC, Chow KM, Lui SF, et al. Independent effects of residual renal function and dialysis adequacy on actual dietary protein, calorie, and other nutrient intake in patients on continuous ambulatory peritoneal dialysis. J Am Soc Nephrol 2001; 12:2450-7.
17. Termorshuizen F, Korevaar JC, Dekker FW, van Manen JG, Boeschoten EW, Krediet RT. The relative importance of residual renal function compared with peritoneal cleara nce for patient survival and quality of life: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. Am J Kidney Dis 2003; 41: 1293-302.
18. Kidney Disease Outcomes Quality Initiative (K/DOQI). K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. Am J Kidney Dis 2004; 43(Suppl 1):S1-290.
19. Piraino B, Bailie GR, Bernardini J, Boeschoten E, Gupta A, Holmes C, et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005; 25: 107-31.
20. Lui SL, Cheng SW, Ng F, Ng SY, Wan KM, Yip T, et al. Cefazolin plus netilmicin versus cefazolin plus ceftazidime for treating CAPD peritonitis: effect on residual renal function. Kidney Int 2005; 68:2375-80.
21. Bettmann MA. Contrast medium-induced nephropathy: critical review of the existing clinical evidence. Nephrol Dial Transplant 2005; 20(Suppl 1):i12-17.
22. Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int 2005; 68: 14-22.
23. Dittrich E, Puttinger H, Schillinger M, Lang I, Stefenelli T, Horl WH, et al. Effect of radio contrast media on residual renal function in peritoneal dialysis patients - a prospective study. Nephrol Dial Transplant 2006; 21:1334-9.
24. Moranne O, Willoteaux S, Pagniez D, Dequiedt P, Boulanger E. Effect of iodinated contrast agents on residual renal function in PD patients. Nephrol Dial Transplant 2006; 21: 1040-5.
25. Menon MK, Naimark DM, Bargman JM, Vas SI, Oreopoulos DG. Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial Transplant 2001; 16:2207-13.
26. Li PK, Chow KM, Wong TYH, Leung CB, Szeto CC. Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. Ann Intern Med 2003; 139:105-12.
27. Suzuki H, Kanno Y, Sugahara S, Okada H, Nakamoto H. Effects of an angiotensin II receptor blocker, valsartan, on residual renal function in patients on CAPD. Am J Kidney Dis 2004; 43:1056-64.
28. Stenvinkel P, Andersson P, Wang T, Lindholm B, Bergström J, Palmblad J, et al. Do ACE-inhibitors suppress tumour necrosis factor-alpha production in advanced chronic renal failure? J Intern Med 1999; 246:503-7.
29. Medcalf JF, Harris KPG, Walls J. Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis. Kidney Int 2001; 59:1128-33.
30. Williams JD, Topley N, Craig KJ, Mackenzie RK, Pischetsrieder M, Lage C, et al. The Euro-Balance trial: the effect of a new biocompatible peritoneal dialysis fluid (Balance) on the peritoneal membrane. Kidney Int 2004; 66:408-18.
31. Szeto CC, Chow KM, Lam CW, Leung CB, Kwan BC, Chung KY, et al. Clinical biocompatibility of a neutral peritoneal dialysis solution with minimal glucose-degradation-products - a one-year randomized control trial. Nephrol Dial Transplant 2006; 22:552-9.
32. Hufnagel G, Michel C, Queffeulou G, Skhiri H, Damieri, Mignon F. The influence of automated peritoneal dialysis on the decrease in residual renal function. Nephrol Dial Transplant 1999; 14:1224-8.
33. Shin SK, Noh H, Kang SW, Seo BJ, Lee IH, Song HY, et al. Risk factors influencing the decline of residual renal function in continuous ambulatory peritoneal dialysis patients. Perit Dial Int 1999; 19:138-42.